View:     View:
tid Target Cancers General Effect on Target
Name
Source
Type

GREM1 encodes Gremlin1, a secreted glycoprotein that acts primarily as an antagonist of bone morphogenetic proteins (BMPs). By modulating BMP signaling, Gremlin1 plays an important role in embryonic development, tissue differentiation, and organogenesis. In cancer, dysregulation of GREM1 can impact cell proliferation, differentiation, and migration, contributing to tumor progression.

Its aberrant overexpression in various cancers correlates with more aggressive tumor features and poorer patient outcomes, positioning it as a promising prognostic biomarker.




(Will delete Record if Target field = "Delete")
 Home